Compounds for treatment of inflammation, diabetes and related disorders
AssigneeTheracos, Inc.
InventorsPartha Neogi, Debedranath Dey, Joseph C. Fuller, Liang Chen, Ta-Kai Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeTheracos, Inc.
InventorsPartha Neogi, Debedranath Dey, Joseph C. Fuller, Liang Chen, Ta-Kai Li
Estimating the term…
Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments including the treatment of diabetes mellitus, insulin resistance, inflammation, inflammatory, diseases, immunological diseases and cancer.
A compound, or salt, hydrate or solvate thereof, represented by at least one of the following Formulas I-XIII:
-65. (canceled)
Dependencies are inferred from the claim text.